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ABSTRACT 
 
 T cells are major mediators of cell-mediated immune responses. T 
cell progenitors originating in the bone marrow enter the thymus, and then 
differentiate, undergo selection, and mature into functional T cells 
through a series of organized and complicated developmental stages. 
These multiple steps in T cell development are regulated by the 
transcriptional control of lineage-specific genes and by the sequential 
rearrangement of T cell receptor (TCR) genes. Switching the transcription 
of various genes, including Notch, GATA-3, E2A/HEB, Id proteins, c-
Myb, ThPOK, Runx complex, and Ikaros family genes, on or off is 
critical for lineage commitment in T cells. In addition, the β-selection and 
positive selection, which depend on the successful rearrangement of TCR 
genes, are essential for the production of mature T cells. Chromatin status, 
which is regulated by histone modification enzymes and chromatin 
remodeling complex, ultimately determines whether gene expression is 
turned on or off.  
 Here, I studied the major components of the murine SWI/SNF 
complex. It was found that BRG1, SNF5, and BAF60a are targeted for 
ubiquitylation and degradation, but that SRG3 can protect them from 
degradation. Previous studies have shown that the SWI/SNF ATP-
dependent chromatin remodeling complex is essential for the 
developmental transitions of thymocytes. In many studies, the stability of 
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the SWI/SNF complex has been shown to be regulated by ubiquitylation. 
In particular, SRG3 stabilizes SNF5, BRG1 and BAF60a by attenuating 
their proteasomal degradation, suggesting its essential role in stabilization 
of the SWI/SNF complex. It was also found that CHFR, an E3 ubiquitin 
ligase and known tumor suppressor that plays an essential role in cell 
cycle control and tumorigenesis, interacts with and ubiquitylates BRG1, 
SNF5, and BAF60a of the SWI/SNF complex, targeting them for 
degradation through a proteasome-mediated pathway. Moreover, It was 
found that SRG3 stabilizes these components by blocking their interaction 
with CHFR.  
 Second, I investigated the function of Bap1, a deubiquitinase 
involved in the regulation of cell growth and proliferation, in thymocyte 
development. Bap1-deficient mice showed developmental retardation in 
embryo and expansion of the myeloid lineage. In this study, to gain 
insight into the contributions of Bap1 to T cell development, the mouse 
Bap1 gene was deleted cell specifically, using Lck-Cre-producing mouse 
strains. The total thymocyte number was significantly reduced in Bap1 
conditional knockout mice. It was found that Bap1 plays a critical role in 
pre-TCR signaling and TCR-mediated T cell development and activation. 
Bap1-deficient T cells displayed the block from stage double negative 
(DN) 3 to DN4, and they exhibited reduced expression of TCRβ 
compared with controls. Thymic positive selection was also significantly 
decreased when Bap1 was knocked out in a TCR transgenic background. 
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TCR-mediated signaling events, including calcium flux and extracellular 
signal-regulated kinase (ERK) activation, were impaired in Bap1-
deficient mice. Additionally, peripheral T cells were not efficiently 
activated upon TCR stimulation. Taken together, these findings suggest 
that Bap1 is a critical component of T cell development and that it 
participates in TCR signaling events required for thymocyte activation.  
From these results, I conclude that: 1) the SWI/SNF chromatin 
remodeling complex for ordinary T cell development is stabilized by 
SRG3 through the blockade of CHFR activity, and 2) Bap1 expression in 
pre-TCR and TCR signal transduction is critical for successful thymocyte 
development and maturation.   
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T cell development, SWI/SNF complex, SRG3, CHFR, Bap1, 
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I-1. Thymocyte development and TCR signaling 
 
 The development of thymocytes from bone marrow-derived 
progenitor cells occurs within the thymus. It is characterized by the 
expression of two surface proteins, CD4 and CD8 coreceptors (Klein et 
al., 2014). The thymic lymphoid progenitor cells in the thymus lack 
expression of the CD4 and CD8, so they are referred to as double-
negative (DN) thymocytes. The DN thymocytes have been further 
subdivided into four stages by the expression of two surface molecules 
CD44 and CD25, as follows: CD44+CD25- (DN1), CD44+CD25+ (DN2), 
CD44-CD25+ (DN3) and CD44-CD25- (DN4) (Ceredig and Rolink, 2002). 
The only DN3 thymocytes that have expressed a functional T cell receptor 
(TCR)-β chain on the surface with pre-Tα and CD3 element to form the 
pre-TCR mature to the CD4+CD8+ double-positive (DP) cells, otherwise 
the development is blocked at DN3 stage. This checkpoint is termed as β-
selection (Shortman and Wu, 1996), which is a cascade of differentiation 
and proliferation events triggered specifically by pre-TCR signaling in 
precursors of TCRαβ T cells, after successful rearrangement of the TCRβ 
gene. Rearrangement is made possible by the expression of the linked 
RAG-1 and RAG-2 recombinase genes and by the accessibility of the 
TCR-coding loci in chromatin at the appropriate stages (Wolfer et al., 
2002). Transcriptional induction of RAG genes and transcription factor- 
mediated opening of the TCR loci thus constitute aspects of T cell specifi- 
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cation.  
 The DP thymocytes are continued to mature by making a 
functional TCR-α chain and subsequently undergo the process of positive 
selection to further develop into either CD4+CD8- or CD4-CD8+ single 
positive (SP) thymocytes, dependent on the affinity of TCRαβ for self 
peptide-loaded major histocompatibility complex (self pMHC) in thymic 
stromal cells. During the process, premature thymocytes with TCR that 
fail to recognize the self pMHC die for the lack of TCR signaling (death 
by neglect), whereas thymocytes with TCR that binds self pMHC with 
high affinity to be eliminated by negative selection. The only thymocytes 
that moderately recognize self-pMHC with the appropriate strength of 
TCR signal can undergo positive selection (Fu et al., 2012; Klein et al., 
2014). When the strength and duration of signaling induced by 
TCR/ligand interaction in the thymus not only determines which cells will 
be positively selected, but also guides them to differentiate into either 
CD4 T cells or CD8 T cells.  
 Differentiation of T cells is continued in the periphery, which 
occurs upon stimulation with antigen, antigen-presenting cells, and 
cytokines (Bosselut, 2004; Singer, 2002). The most proximal event 
associated with TCR ligation is the activation of tyrosine kinases, 
including Zap70, Itk, Lck and Fyn. After ligation of the TCR, the Src-
family kinase Lck phosphorylates tyrosine residues in immunoreceptor 
tyrosine-based activation motifs of the invariant signaling protein CD3ζ   








Figure 1. Overview of thymocyte development  
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complex, which is followed by the recruitment and activation of Zap70. 
Activated Zap70 phosphorylates the adaptor Lat, which results in the 
formation of the multimolecular signalosome complex known as the ‘Lat 
signalosome’, which includes PLC-γ1, Grb2, Vav, Gads, SLP-76 and 
Themis (Brockmeyer et al., 2011; Werlen and Palmer, 2002). Recruitment 
to the Lat signalosome activates these signaling molecules, leading to 
subsequent activation of signaling cascades, including the mitogen-
activated protein kinase Erk and calcium mobilization, which are 
hallmarks of TCR signaling and are critical for the survival, 
differentiation and maturation of thymocytes (Kane and Hedrick, 1996). 
Deletion or manipulation of intracellular kinases such as Lck, Zap70, Tec-
family kinases and Erk results in defective thymocyte selection. 
 
I-2. SWI/SNF chromatin remodeling complexes   
 
 The dynamic modification of chromatin structure allows access of 
condensed DNA to the transcription machinery proteins for gene 
expression. The chromatin status that is accessible or inaccessible to the 
transcription machinery is very closely related to the gene expression 
(Razin, 1998). Chromatin remodeling complex is a fundamental regulator 
involved in all major reactions with chromatin substrate. Chromatin 
remodeling complexes use the energy of the ATP hydrolysis to change the 
condensed chromatin structure (Becker and Hörz, 2002). The family of 
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ATP-dependent chromatin remodeling complexes can be subdivided into 
five different classes: SWI/SNF, ISWI, NuRD/Mi2/CHD, INO80, and 
SWR1. Because each complex bears unique flanking domains, although 
all complexes share a conserved ATPase domain, the chromatin 
complexes are distinguishable: That is, BRG or BRM, SNF2H, and Mi2, 
for BAF, ISWI and NURD complexes, respectively (Flaus et al., 2006; 
Lusser et al., 2005).  
 The SWI/SNF complex is highly conserved multi-subunit 
complex (Kingston and Narlikar, 1999; Muchardt and Yaniv, 1999), 
which was first discovered in yeast (Winston and Carlson, 1992). Human 
SWI/SNF complexes contain a single ATPase, either BRM (encoded by 
the SMARCA2 gene) or BRG1 (SMARCA4), and three main core subunits: 
BAF155 (SMARCC1), BAF170 (SMARCC2), and BAF47 (SMARCB1). 
These complexes divided into two main types, depending upon their 
subunit composition: BAF complexes contain either BAF250a (ARID1A) 
or BAF250b (ARID1B) subunits; PBAF complexes contain BAF180 
(PBRM1) and BAF200 (ARID2) subunits. In addition to these core 
subunits, SWI/SNF complexes contain 7 to 15 accessory subunits. 
Subunit diversity of the mammalian SWI/SNF complex suggests different 
complexes might have tissue-specific roles (Wang et al., 1996).  
 The accessibility of the SWI/SNF complex to chromatin is 
regulated by TCR signaling. TCR signaling induces the rapid association 
of the SWI/SNF complex with chromatin in peripheral T cells (Zhao et al., 
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1998). Polycomb repressive complex 1 (PRC1) has been shown to 
negatively regulate chromatin accessibility of the SWI/SNF complex 
(Shao et al., 1997). The chromatin remodeling activity of the SWI/SNF 
complex is also regulated by phosphorylation in cellular processes, 
particularly during mitosis. BRG1 and hBRM undergo phosphorylation 
on entry into mitosis, which might be used as a switch to modulate the 
SWI/SNF complex activity during cell cycle (Muchardt et al., 1996; 
Reyes et al., 1997). The stability of the SWI/SNF complex is reported to 
be regulated by ubiquitylation. Unkempt, a RING finger protein, binds to 
BAF60b and induces its ubiquitylation and proteosomal degradation 
(Lorès et al., 2010). BAF57 is also ubiquitylated and degraded by the E3 
ubiquitin ligase, Thyroid hormone receptor interacting protein 12 
(TRIP12). BAF155 blocks the interaction between BAF57 and TRIP12 
and, thus, protects BAF57 from degradation (Keppler and Archer, 2010). 
These results suggest that protein degradation by the ubiquitylation 
pathway regulates the quality and functional fidelity of the SWI/SNF 
complex. 
 
I-3. SRG3, a scaffold subunit of the SWI/SNF complex  
 
 Srg3 (Swi3-related gene) is a murine homolog of yeast Swi3, 
Drosophila Moira, and human Baf155 (Sudarsanam and Winston, 2000), 
was initially isolated as a highly expressed gene in thymus but not in 
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spleen (Jeon et al., 1997). It was reported that BAF155 was essential for 
the chromatin remodeling function of BRG1 (Kadam, 2000). The 
expression level of SRG3 is critical for glucocorticoid (GC) sensitivity in 
thymocytes (Han et al., 2001; Jeon et al., 1997; Ko et al., 2004a). In 
addition, during positive selection of thymocytes, TCR signaling induces 
the expression of Id3 protein, which blocks the activity of E2A protein 
and thereby downregulates the SRG3 expression (Ko et al., 2004a; Ko et 
al., 2004b). SRG3 also regulated by Notch signaling during DP thymocyte 
maturation (Choi et al., 2001; Jang et al., 2006) and Nitric oxide (NO) 
signaling represses SRG3 expression via the inactivation of the 
transcription factor SP1’s DNA binding activity to the SRG promoter 
(Jeong et al., 2004).  
 Previous studies have shown that SRG3 has a scaffold function in 
stabilizing the SWI/SNF by interacting directly with the core subunits 
BRG1, SNF5, and BAF60a (Sohn et al., 2007). SRG3 interacts with 
BRG1 through its highly conserved SANT (SWI3, ADA2, N-CoR, and 
TFIIIB) domain (Aasland et al., 1996). It also interacts with SNF5 and 
BAF60a through its conserved SWIRM (SWI3, RSC8, and MOIRA) 
domain. SRG3 also interacts with other components of the SWI/SNF 
complex and stabilizes them by attenuating or blocking their proteasomal 
degradation (Sohn et al., 2007). It has also been reported that MOIRA and 
BAF155 interact with BRM and BAF57, respectively (Crosby et al., 
1999; Keppler and Archer, 2010). These results suggest that SRG3 is a   










Figure 2. The SWI/SNF chromatin remodeling complex 
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scaffold that interacts physically with other components of the SWI/SNF 
chromatin remodeling complex and stabilizes them.  
 
I-4. The function of SWI/SNF complex in thymocyte development 
 
 In the past few years, many studies have shown to address the 
roles of the SWI/SNF complexes in the immune system from lymphocyte 
development to immune responses. T-cell-specific inactivation of 
SWI/SNF complexes indicates that they are essential for the 
developmental transitions of thymocytes. The SWI/SNF complexes serve 
a central role in the regulation of genes involves in hematopoietic lineage 
specification. For example, Interaction of SWI/SNF complexes with 
Ikaros, a zinc finger transcription factor that is important in lymphocyte 
development, provide a relation between chromatin modification and 
hematopoietic cell fate decisions (Georgopoulos, 2002). The sustained 
expression of dominant negative mutant of BAF57 resulted in the de-
repression of CD4 and the inactivation of CD8 expression in immature T 
cell subsets (Chi et al., 2002). The downregulation of IL-2Rα (CD25) 
transcription at DN stage was correlated with dissociation of histone 
acetylase p300 and BRG1 from its promoter (Yeh et al., 2002). In 
addition, the deficiency of Brg1 led to the impairment of CD4/CD8 
expression in DN cells and reduction of cell viability of DP cells (Chi et 
al., 2003; Gebuhr et al., 2003). Brg1 is also critical for innate and adaptive 
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immune responses. BRG1 selectively activates a subset of interferon-α-
inducible genes and functions downstream of TCR signaling to 
decondense chromatin during T-cell activation (Huang et al., 2002; Zhao 
et al., 1998). These results implicated that the SWI/SNF complex 
mediates the expression of genes involved in thymocyte development and 
immune responses.  
 
I-5. The Ubiquitin-Proteasome system  
 
 Ubiquitin is a highly conserved 76 amino acids polypeptide in 
eukaryotes. The cascade of E1, E2 and E3 enzymes conjugates ubiquitin 
to lysine residues (Pickart, 2001). In humans, there are two E1 enzymes, 
about forty E2 enzymes and hundreds of E3 enzymes.  A protein can be 
modified on one lysine residue with a single ubiquitin (mono-
ubiquitylation) or with a chain of ubiquitin (poly-ubiquitylation). Lysine 
48 (K48)-linked poly-ubiquitylation usually targets proteins for 
proteasomal degradation, whereas K63-linked poly-ubiquitylation is 
implicated in many signal transduction cascades, such as DNA repair and 
protein kinase activation (Chen et al., 2009). The proteasome is a 
complicated molecular machine, which perform to degrade proteins 
following their conjugation to ubiquitin (Herrmann et al., 2007; 
Welchman et al., 2005). The proteasome has a proteolytic subunit and an 
ATP-dependent regulatory subunit, functionally linked by a gated protein   
















Figure 3. The Ubiquitin-Proteasome system 
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translocation channel. The proteasome exists in multiple forms, but 
contains two major assemblies, the 28-subunit core particle (CP, also 
known as the 20S particle) and a regulatory particle (RP, also known as 
the 19S particle and PA700). The CP is a barrel-like structure whose 
subunits are arranged in four stacked seven-membered rings (Borissenko 
and Groll, 2007). The proteolytic active sites of proteasome are imbedded 
within the internal space of the CP. The poly-ubiquitylated proteins are 
recognized by the RP, and then enter the inside of the CP in contact with 
proteolytic active sites and degrade to peptide fragments. In eukaryotes, 
the ubiquitin-proteasome degradation pathway is the major proteolytic 
system with functions in diverse biological processes such as cell cycle, 
apoptosis, inflammation, transcription, signal transduction and protein 
quality control (Huang and D'Andrea, 2006; Li et al., 2009; 
Mukhopadhyay and Riezman, 2007). 
 
I-6. CHFR, an E3 ubiquitin ligase  
 
 Specificity in the choice of ubiquitylation substrate and the type 
of ubiquitin chain is largely determined by E2 and E3 enzymes (Ye and 
Rape, 2009). The E3 ligases,	  which specifically binds a protein substrate 
and facilitates the transfer of ubiquitin from E2 to a lysine residue in the 
substrate (Pickart, 2001; Weissman, 2001), are classified into two 
families: HECT (homologous to the E6-associated protein C terminus), 
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RING (Really Interesting New Gene)-finger. CHFR (Checkpoint with 
FHA and RING finger domains) is one of the E3 ubiquitin ligases, which 
is known to be a tumor suppressor and play an essential role in cell cycle 
control and tumorigenesis.  CHFR is inactivated in various tumors, 
including colorectal, gastric, lung, and breast (Ogi et al., 2014; Satoh et 
al., 2003; Toyota and Suzuki, 2010). CHFR controls Aurora A protein 
levels through ubiquitylation, consequently, overexpression of Aurora A 
in cancer may be explained in part by inactivation of CHFR. CHFR 
knockout mice develop solid tumors and lymphomas, and embryonic 
fibroblasts from CHFR knockout mice show a mitotic checkpoint defect 
that causes chromosomal instability (Yu et al., 2005). In addition, CHFR 
interacts with helicase-like transcription factor (HLTF), which belongs to 
the SWI/SNF family and is silenced by promoter hypermethylation in 
colorectal, gastric, and cervical cancers (Hamai et al., 2003), and 
negatively-regulates its stability and functions by ubiquitylation (Kim et 
al., 2010).  
 
I-7. BAP1, a deubiquitinating enzyme  
 
 Ubiquitylation can be reversed by deubiquitinating enzymes 
(DUBs), which form a large group of proteases. DUBs can reverse 
ubiquitylation by cleaving the peptide or isopeptide bond between 
ubiquitin and its substrate protein. In humans, there are almost one   


















Figure 4. The structure of deubiquitinase BAP1 and its protein 
partners  
 UCH, Ubiqiutin carboxyl-terminal hydrolase domain; HBM, 
HCF-1- binding motif; ULD, UCH37-like domain.  
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hundred putative DUB genes, which can be classified into two main 
classes: cysteine proteases and metalloproteases (Finley, 2009). There are 
four main superfamilies of cysteine protease DUBs, the ubiquitin-specific 
protease (USP/UBP) superfamily: the ovarian tumor (OTU) superfamily, 
the Machado-Josephin domain (MJD) superfamily and the ubiquitin C- 
terminal hydrolase (UCH) superfamily. The JAB1/MPN/Mov34 
metalloenzyme (JAMM) domain superfamily proteins are zinc-dependent 
metalloprotease family (Amerik and Hochstrasser, 2004). The 
deubiquityation is a highly regulated process that has been implicated in 
numerous cellular functions, including cell cycle regulation, proteasome- 
and lysosome-dependent protein degradation, gene expression and DNA 
repair (Daniel and Grant, 2007; Song and Rape, 2008). A number of 
pathogenic microorganisms have acquired genes encoding DUBs 
suggesting that disruption of ubiquitylation in the host cell may confer a 
selective advantage for these bacteria and viruses (Lindner, 2007; 
Rytkönen and Holden, 2007). Furthermore, mutations in several 
deubiquitinating enzymes have been linked to disease ranging from 
cancer to neurological disorders (Fischer, 2003).  
 BRCA1-associated protein-1 (BAP1) is a nuclear 
deubiquitinating enzyme (DUB) that was identified as breast cancer type 
1 susceptibility protein (BRCA1)-interacting ubiquitin carboxyl-terminal 
hydrolase (UCH) that is involved in the removal of ubiquitin from 
proteins (Jensen et al., 1998; Nishikawa et al., 2009). Many studies have 
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shown that BAP1 roles as a tumor suppressor (Jensen and Iii, 1999). 
BAP1 was inactivated in lung carcinoma, breast cancer cell lines, and 
renal cell cancers (Abdel-Rahman et al., 2011; Coupier et al., 2005; 
Jensen et al., 1998; Ventii et al., 2008). Somatic and germline BAP1 
mutations also increased the possibility of mesothelioma and uveal 
melanoma (Abdel-Rahman et al., 2011; Goldstein, 2011; Testa et al., 
2011). In addition, RNA interference (RNAi)-mediated depletion of 
BAP1 induced cell-cycle progression defects such as the S-phase 
retardation (Nishikawa et al., 2009).  
 The Drosophila gene calypso, a homologue of the human BAP1 
gene, is a Polycomb group (PcG) gene, which is transcriptional repressor 
that regulates cell differentiation and development (Scheuermann et al., 
2010). Calypso interacts and makes a complex with Asx (Additional sex 
combs) that is homologous of the human Asxl1 (Additional sex combs-
like 1), where the complex was named Polycomb repressive 
deubiquitinase (PR-DUB). The complex binds at PcG target genes in 
Drosophila, and then, removes mono-ubiquitin from histone H2A, which 
leads the chromatin remodeling and gene silencing (Figure 5A). In 
humans, BAP1 interacts with Additional sex combs-like 1 (ASXL1) 
through its carboxyl-terminal and deubiquitinates histone H2A and 
regulates expression of target genes. It had been observed that the 
ubiquitin of H2A level was subsequently changed when the level of BAP1 
was altered in renal cancer cells (Peña-Llopis et al., 2012). BAP1 regulate   























Figure 5. The mechanism of BAP1 functions   
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gene transcription via association with other protein partners (Figure 5B). 
BAP1 interacts with the zinc fingers of YY1 through its coiled- coil motif 
and it is recruited together with HCF1 to the promoter of the gene that 
encodes a component of the mitochondrial respiratory chain (Yu et al., 
2010). Also, deubiquitylating activity of BAP1 controls stability of target 
proteins (Figure 5C). The transcriptional regulator host cell factor-1 
(HCF-1) and its interacting partner O-linked N-acetylglucosamine 
transferase (OGT), which itself positively regulates HCF-1 activity by 
glycosylation (Dey et al., 2012), are stabilized through deubiquitylation 
by BAP1. This complex plays a critical role in glucose sensing. Levels of 
the promoter of gluconeogenesis, peroxisome proliferator-activated 
receptor-γ coactivator (PGC)-1α, are increased in euglycemic conditions. 
It is proposed that N-acetylglucosylation of PGC-1α by HCF-1/OGT 
promotes its stability, through the recruitment of BAP1 deubiquitylating 
activity (Yang et al., 2012). 
 
I-8. The function of BAP1 during hematopoiesis 
 
 Although the molecular mechanism still remains elusive, several 
evidences have been shown that BAP1 is also involved in hematopoiesis. 
The deletion of BAP1 in murine model resulted in embryonic lethality 
(Dey et al., 2012). The inducible deletion of BAP1 using creERT2 system 
showed severe splenomegaly resulted from extramedullary hematopoiesis 
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and expansion of the myeloid lineage. Total leukocytes cellularity was 
increased because of monocytosis and neutrophilia. Overall, BAP1 
deletion showed the features of myeloprolitive and myelodysplastic 
disorder that resembles human chronic myelomonocytic leukemia 
(CMML) (Dey et al., 2012). Furthermore, the systemic deletion of BAP1 
at the hematopoietic stem cells (HSCs) led to an increase in the number of 
LSK (lineage-negative, Sca-1+, c-Kit+) and myeloid progenitor cells in the 
bone marrow. BAP1-deficient bone marrow progenitors exhibited 
decreased self- renewal as assayed by in vitro colony-forming assays and 
competitive transplantation assays using whole bone marrow 
mononuclear cells depleted of BAP1 before transplantation. Nevertheless, 
much remains unknown about the roles of BAP1 during thymocytes 
development in the thymus.   











MATERIALS AND METHODS 
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Plasmid constructs 
 For cloning of plasmids used in transfection, the cDNAs for 
murine SRG3, BRG1, SNF5, and BAF60a were inserted into the 
pCAGGS or pCAGGSBS vector with N-terminal FLAG or Myc tag. The 
mutants of SNF5 were PCR-amplified with appropriate primers for 
FLAG-SNF5 (1–319), -SNF5 (1–245), and -SNF5 (1–185 + Rpt2) and 
inserted into the pCAGGSBS vector. Each construct was tagged with N-
terminal FLAG epitope. The pcDNA3-Myc-CHFR plasmid construct and 
HA-Ubiquitin plasmid construct were generously provided by JH, Seol 
(Seoul National University, Seoul, Korea) and CH, Chung (Seoul 
National University, Seoul, Korea), respectively.  
 
Cell culture and transient transfection 
 COS-1 cells and 293T cells were cultured in Dulbecco’s modified 
Eagle’s medium (DMEM, WelGENE) containing 10% fetal bovine serum 
(FBS, WelGENE). NIH3T3-U6 and NIH3T3-U6-shSRG3 stable cell lines 
were maintained in DMEM containing 10% bovine calf serum (BCS, 
HyClone). All the transfection experiments were performed with 
Lipofectamine 2000 (Invitrogen), CaPO4-method or polyethyleneimine 
(PEI) according to the manufacturer’s instructions. All cells were split 
into 60 mm dishes to 70–80% confluency at 24 h before transfection. 
Appropriate control empty vectors were supplemented to adjust the total 
amounts of DNA in each experiment. Cells were harvested after 48 h of 
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incubation. Before the harvesting, the cells were treated with 20 µM of 
MG132 (A.G. Scientific, INC.) for 6 h. 
 
Immunoprecipitation, and immunoblotting 
 For immunoprecipitation experiments, cells were lysed in buffer 
X (100 mMTris–Cl pH 8.5, 250 mM NaCl, 1% NP-40, 1 mM EDTA, 2 
mg/ml BSA) and the proteins were immunoprecipitated with specific 
antibodies as previously described. For Immunoblot analysis, cells were 
lysed in RIPA buffer in the presence of protease inhibitors. Proteins were 
subjected to SDS–PAGE and transferred to immobilon-P membrane 
(Millipore). Blotted proteins were detected using antibodies of anti-FLAG 
(M2, Sigma), anti-Myc (9E10, Roche Applied Science), anti-HA (HA-7, 
Sigma), anti-BAP1 (H-300, Santa Cruz) and anti-β-actin (AC-15, Sigma) 
were purchased commercially. Antisera against SRG3 were raised from 
rabbits in our laboratory.  
 
In vitro ubiquitylation assay 
 For in vitro ubiquitylation assay, FLAG-BRG1, FLAG-SNF5 or 
FLAG-BAF60a translated in vitro by using TNT T7 quick coupled system 
(Promega, L1170) was incubated at 37 °C for 0 or 30 min with E1 (0.5 
µg), E2 (UBCH5a, 0.5 µg), ubiquitin (10 µg), 1 mM DTT, and 5 mM 
ATP in the presence or absence of E3 (His-CHFR, 7 µg) as previously 
described. After the indicated times, each sample was analyzed by 
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immunoblotting with anti-SNF5, -BAF60a, or -BRG1 antibodies. 
 
Mice 
 Mice with loxP sites between 12 and 13 exon of Bap1 were 
provided by Soo-Jong Um (Sejong University, Seoul, Korea), which was 
crossed with Flp-transgenic mice to remove the neo selection cassette. 
These Bap1fl/fl mice were crossed to the Lck-Cre or CD4-Cre mice. Lck-
Cre, CD4-Cre and HY TCR transgenic mice were purchased from 
Taconic. RAG knockout mice were purchased from the Jackson 
Laboratory. All mice were bred and maintained in pathogen-free barrier 
facilities at Seoul National University and used according to protocols 
approved by Institutional Animal Care and Use Committees (IACCU) of 
Seoul National University.  
 
Flow cytometry and cell sorting 
 Single-cell suspensions from the thymus, spleen and lymph node 
were prepared by passing through the cell strainer to get rid of cell 
debris and surface stained as described (ref). To deplete the red blood 
cells, an equal volume of ACK RBC lysis buffer (155 mM NH4Cl, 10 mM 
KHCO3 and 0.1 mM EDTA) was added to the cells, and then incubated 
on room temperature for 5 min. Then up to 10 ml of 1X PBS was added to 
stop the lysis reaction. Cells were stained with antibodies in various 
combinations in 1X PBS. Flow cytometry analyses were performed using 
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FACSCanto II (BD Bioscience). The antibodies used are as follows: Anti-
CD4-PE (GK1.5, BD), -CD4-PE-Cy7 (GK1.5, eBioscience), -CD8-APC-
Cy7 (53-6.7, eBioscience), -CD25-PE (PC61, BD), -CD25-PE-Cy7 
(PC61.5, eBioscience), -CD44-FITC (IM7, eBioscience), -CD69-Biotin 
(BD), -CD44-Biotin (IM7, eBioscience), -TCRβ-FITC (H57-597, BD), -
HY-APC (T3.70, eBioscience), -CD24-PE-Cy7 (M1/69, BioLegend), -
CD62L-FITC (MEL-14, BD), -mouse IgG1-PE (A85-1, BD), -IgG-FITC 
(BD), -Streptavidin-PerCP (BD). FACS AriaII (BD Bioscience) was used 
for sorting of cells.  
 
Hematoxylin and eosin staining 
 Thymi were fixed in 4% paraformaldehyde and 0.05% 
glutaraldehyde in phosphate-buffered saline (PBS) for 2h at 4°C, 
embedded in paraffin, and serially sectioned (5µm). Some sections were 
stained with routine hematoxylin-eosin.  
 
Quantitative RT-PCR analysis 
 Total RNA was purified from cells with TRIzol® reagent 
according to the manufacturer’s instructions (Invitrogen). RNA was 
reverse transcribed with SuperScript III (Invitrogen) and diluted cDNAs 
were analyzed by quantitative real-time PCR. SYBR Green PCR mix 
(Applied Biosystem) was used for quantitative RT PCR and the results 
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were quantified with StepOnePlus (Applied Biosystem). The showed data 
were relative values. Primer sequences are available upon request. 
 
CD69-upregulation assay 
 Sorted naive splenocytes were stimulated for 5 hours with plate-
bound anti-CD3 (5 µg/ml) and anti-CD28 (5 µg/ml) at 37°C. Cells were 
stained with anti-CD69 antibody and anti-CD4 or anti-CD8 antibody and 
analyzed after gating CD4+ or CD8+ cells.  
 
Ca2+ flux 
 A total of 5 x 106 Thymocytes were labeled in RPMI medium 
containing Fluo-3 (Invitrogen), in the presence of Pluronic (Invitrogen) 
for 30 min at 37°C. Cells the washed with RPMI twice. After adding anti-
CD3ε-biotin antibody, cells were incubated on ice for 15min, washed 
twice with RPMI medium, and resuspended in 1x HBS solution. Cells 
were prewarmed to 37°C before analysis and then collected on a 
FACSCanto II (BD bioscience) for 30 sec to establish a baseline for 
unstimulated cells and the change in the Ca2+ flux was monitored for the 
following 5 min. For cell stimulation, prewarmed streptavidin (10 µg/ml) 
was added to cells. Mean fluorescence ration was calculated with FlowJo 
(Tree star).  
 
Intracellular staining  
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 After surface staining on CD25, CD44, CD4 and CD8, single cell 
suspension of total thymocytes was fixed and permeabilized with 
Fixation/Permeabilization buffer (BD Bioscience) according to the 
manufacturer’s instructions. Cells were stained with anti-TCRβ antibody 
(BD Bioscience). For phosphor-ERK staining, cells were stained with 
phospho-ERK specific antibody, followed by staining with PE-conjugated 
anti-mouse IgG1 antibody. Cell events were collected by using a 
FACSCanto II (BD bioscience), and the data was analyzed with FlowJo 
(Tree star).  
 
Statistical analysis 
 Prism software (Graphpad) was used for all statistical analysis. 
Two-tailed Student’s t-tests were used to calculate p values where 
indicated. 
  









CHAPTER III.  
 
RESULTS 
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III-1. SRG3 stabilizes the SWI/SNF complex by blocking CHFR 
mediated ubiquitylation and degradation 
 
Major components of the SWI/SNF complex interact with CHFR  
 
 BRG1, SNF5, and BAF60a are degraded by a proteasome-
mediated degradation pathway (Sohn et al., 2007). The degradation of 
BRG1, SNF5, and BAF60a was inhibited by treatment with the potent 
proteasome inhibitor MG132, and SNF5 protein was poly-ubiquitylated 
(Sohn et al., 2007). It was tested whether BAF60a and BRG1 are also 
poly-ubiquitylated in the presence of MG132 (Figure 6A and B). 
Significant increases in BAF60a-ubiquitin and BRG1-ubiquitin 
conjugates were detected in the presence of MG132. These results show 
that BAF60a and BRG1, as well as SNF5, are ubiquitylated and regulated 
by a proteasome-mediated degradation pathway.  
 CHFR is known to function as a mitotic checkpoint protein and as 
an ubiquitin ligase for HLTF (Ding et al., 1996; Kim et al., 2010). These 
results suggested the possibility that CHFR may function as an E3 
ubiquitin ligase for the components of the SWI/SNF complex. Therefore, 
It was analyzed the interaction between the components of the 
mammalian SWI/SNF complex and CHFR by immunoprecipitation. The 
expression vectors of FLAG-tagged BRG1, SNF5, BAF60a, or SRG3 
were co-transfected with Myc-CHFR expression vector into COS-1 cells, 
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and cell lysates were immunoprecipitated with anti-FLAG or anti-Myc 
antibodies. As shown in Figure 7A–D, BRG1, SNF5, and BAF60a were 
co-immunoprecipitated with CHFR, whereas SRG3 did not interact with 
CHFR at all. These results suggest that BRG1, SNF5, and BAF60a, but 
not SRG3, are the substrates of CHFR for ubiquitylation.  
 
CHFR induces ubiquitylation of major components of the SWI/SNF 
complex  
 
 I further examined whether CHFR actually induces ubiquitylation 
of the components of the SWI/SNF complex, both in vitro and in vivo. For 
the in vitro ubiquitylation assay, FLAG-tagged BRG1, SNF5, or BAF60a, 
which were translated in vitro, incubated with or without CHFR for the 
indicated times. As shown in Figure 8A–C, the ubiquitylation of BRG1, 
SNF5, or BAF60a increased when these proteins were incubated with 
CHFR for 30 minutes. To confirm that CHFR induces ubiquitylation in 
vivo, 293T cells were co-transfected with FLAG-SNF5 and HA-Ubiquitin 
expression vectors, with or without Myc-CHFR expression vector, and 
cell lysates were immunoprecipitated with anti-FLAG antibody (Figure 
9). In the presence of CHFR, the SNF5-ubiquitin conjugates significantly 
increased, indicating that CHFR induces the ubiquitylation of SNF5 in 
vivo. 
 Next, It was investigated whether CHFR can increase the degrad-  













Figure 6. The components of the SWI/SNF complex are poly-
ubiquitinated by the proteasome-mediated pathway.  
 
COS-1 cells were co-transfected with FLAG-BAF60a (A) or FLAG-
BRG1 (B) expression vectors along with HA-Ubiquitin expression vector. 
After 42 hours of incubation, cells were treated with MG132 (20 µM) for 
6 hours. Whole cell lysates were immunoprecipitated with anti-FLAG 
antibody and subjected to immunoblot analysis with anti-HA antibody 
(upper panel). The membranes were stripped after analysis and 
immunoblotted again with anti-FLAG antibody (lower panel).   







Figure 7. The major components of the SWI/SNF complex interact 
with CHFR. 
 
FLAG-SNF5 (A), FLAG-BAF60a (B), FLAG-BRG1 (C) or FLAG-SRG3 
(D) expression vectors were co-transfected into COS-1 cells with Myc-
CHFR expression vectors. Whole cell lysates were immunoprecipitated 
with anti-FLAG or anti-Myc antibodies and subjected to immunoblot 
analysis with anti-Myc or anti-FLAG antibodies, respectively. The cells 
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ation of its substrates, BRG1, SNF5, and BAF60a. 293T cells were co-
transfected with FLAG-BRG1, -SNF5, or -BAF60a expression vector 
together with the Myc-CHFR expression vector (Figure 10A–D). CHFR 
downregulated the stability of these components in a dose-dependent 
manner. In the presence of MG132, the protein levels were restored to 
those at which CHFR was not overexpressed. These findings indicate that 
CHFR increases the degradation of BRG1, SNF5, and BAF60a through 
the ubiquitylation-proteasome-mediated degradation pathway. However, 
SRG3 protein was not affected by CHFR overexpression at all. As 
described previously, unlike other components, SRG3 did not interact 
with CHFR. Thus, CHFR regulates the stability of the components of the 
SWI/SNF complex by inducing ubiquitylation but does not affect SRG3 
level. In addition, the SNF5-ubiquitin conjugates significantly increased 
in the presence of MG132 with CHFR in vivo. These results suggest that 
CHFR enhances the degradation of the components of the SWI/SNF 
complex by inducing their poly-ubiquitylation.  
 
SRG3 can stabilize the SWI/SNF complex by interfering with CHFR  
 
 Since SRG3 and CHFR have opposite roles in stabilizing the 
subunits of the SWI/SNF complex, it is likely that SRG3 inhibits the 
activity of CHFR for regulation of protein stability of those components.   










Figure 8. CHFR enhances the degradation of the SWI/SNF complex 
in vitro by inducing its ubiquitination.  
 
For in vitro ubiquitination assay, in vitro translated FLAG-SNF5 (A), 
FLAG-BAF60a (B) or FLAG-BRG1 (C) were incubated with E1, E2 
(UBC-5Q), ubiquitin, ATP, DTT, protease inhibitor, and His-CHFR for 
the indicated times at 37℃. After incubation, the samples were 
immunoblotted with anti-SNF5, -BAF60a, or -BRG1 antibodies. To 
verify this, BRG1, SNF5, or BAF60a expression vectors were co- 
transfected together with increasing amounts of CHFR expression vector   













Figure 9. CHFR induces the ubiquitination of SNF5 in vivo. 
 
293T cells were co-transfected with FLAG-SNF5 and HA-Ubiquitin 
expression vectors, and treated with MG132 (20 µM) or vehicle for 6 
hours. After 48 hours of incubation, whole cell lysates were subjected to 
SDS-PAGE and immunoblotted with anti-Myc or anti-FLAG antibodies 
(left panel). Also, the cell lysates were immunoprecipitated with anti-
FLAG antibody and subjected to SDS-PAGE, and immunoblotted with 
anti-HA antibody (right, upper panel) or anti-FLAG antibody (right, lower 
panel).  






Figure 10. CHFR increases the degradation of the components of the 
SWI/SNF complex through the ubiquitination-proteasome-mediated 
pathway.  
 
293T cells were co-transfected with FLAG-SNF5 (A), FLAG-BAF60a 
(B), FLAG-BRG1 (C), or FLAG-SRG3 (D) expression vectors along with 
increasing amount of Myc-CHFR expression vector. Cells were treated 
with MG132 (20 µM) for 6 hours and whole cell lysates were analyzed by 
immunoblot analysis with anti-Myc and anti-FLAG antibodies. 
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and a fixed amount of SRG3 expression vector into 293T cells and 
analyzed the protein levels of each component by immunoblot analysis. 
As shown in Figure 11A–C, the protein levels of BRG1, SNF5, and 
BAF60a were downregulated by CHFR expression but were maintained 
in the presence of SRG3, although the level of CHFR was not 
significantly changed. These results suggest that the degradation of the 
components of the SWI/SNF complex induced by CHFR is inhibited by 
SRG3 expression. It was further examined whether the protein stability 
and ubiquitylation of BAF60a is affected by Srg3 knockdown. The 
established NIH3T3 cell line stably expressing small hairpin RNA against 
Srg3 (shSRG3) and its control cell line (Ahn et al., 2011) were co-
transfected with FLAG-BAF60a expression vector and HA-Ubiquitin 
expression vector (Figure 12). BAF60a level was decreased by 
knockdown of Srg3 and restored by MG132 treatment. Cell lysates were 
immunoprecipitated with anti-FLAG antibody and then immunoblotted 
with anti-HA antibody for detecting ubiquitylated BAF60a proteins. In 
the presence of MG132, the ubiquitylation of BAF60a was increased by 
Srg3 knockdown. Thus, SRG3 stabilizes BAF60a by inhibiting the 
ubiquitylation of BAF60a, which is induced by CHFR. 
 
Rpt2 region of SNF5 is the CHFR-interacting region  
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 Alignment analysis of SNF5 and its homologs revealed that SNF5 
has 2 highly conserved domains, namely, repeat 1 (Rpt1) and repeat 2 
(Rpt2), and 1 moderately conserved domain, namely, homology region 3 
(HR3) (Craig et al., 2002; Morozov et al., 1998). To identify which 
regions of SNF5 are important for the interaction with CHFR, several 
deletion mutants of SNF5 were generated (Figure 13A). FLAG-tagged 
wild-type SNF5 and its mutants were co-expressed with Myc-CHFR in 
COS-1 cells, and cell lysates were immunoprecipitated with anti-FLAG 
antibody and immunoblotted with anti-FLAG and anti-Myc antibodies 
(Figure 13B). The HR3 deletion mutant of SNF5 [SNF5 (1–319)] 
interacted with CHFR, but the Rpt2 and HR3 deletion mutant of SNF5 
[SNF5 (1–245)] did not. In addition, when the Rpt1 region was replaced 
by the Rpt2 region [SNF5 (1–185+Rpt2)], the deletion mutant interacted 
with CHFR. Taken together, these results suggest that SNF5 interacts 
with CHFR through the Rpt2 region of SNF5.   






Figure 11. SRG3 can stabilize the SWI/SNF complex by interfering 
with CHFR.  
 
FLAG-SNF5 (A), FLAG-BAF60a (B), or FLAG-BRG1 (C) expression 
vectors were co-transfected into 293T cells along with increasing amount 
of Myc-CHFR expression vector in the absence or presence of FLAG-
SRG3 expression. After 48 hours of incubation, whole cell lysates were 

















Figure 12. SRG3 stabilizes the BAF60a by inhibiting the 
ubiquitination of BAF60a. 
 
NIH3T3-U6 control and NIH3T3-U6-shSRG3 stable cell lines were co-
transfected with FLAG-BAF60a and HA-Ubiquitin expression vectors. 
After 42 hours of incubation, cells were treated with MG132 (20 µM) or 
vehicle for 6 hours. Whole cell lysates were immunoblotted with anti-
FLAG or anti-SRG3 antibodies (left panel). Also, the cell lysates were 
immunoprecipitated with anti-FLAG antibody and subjected to SDS-
PAGE, and immunoblotted with anti-HA antibody (right panel).  





Figure 13. Rpt2 region of SNF5 is CHFR-interacting region and 
responsible for the degradation of SNF5 by CHFR.  
 
(A) The schematic representation of deletion mutants of SNF5 is depicted. 
The Rpt1, Rpt2, and HR3 regions are indicated with solid black box, gray 
box, and white box, respectively. Each SNF5 mutant was tagged with 
FLAG epitope (not shown). (B) The interactions between deletion 
mutants of SNF5 and CHFR were analyzed by immunoprecipitation. 
COS-1 cells were co-transfected with FLAG-tagged wild type or mutant 
SNF5 expression vectors with Myc-CHFR expression vector. After 48 
hours of incubation, whole cell lysates were immunoprecipitated with 
anti-FLAG antibody and subjected to SDS-PAGE, and immunoblotted 
with anti-Myc and anti-FLAG antibodies.   
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III-2. Thymocyte-specific deletion of the deubiquitinase Bap1 impairs 
thymocyte development and activation  
 
Bap1 is highly expressed in the thymus  
 
 Bap1 mRNA is expressed in several tissues, including brain, testis, 
placenta, and breast (Jensen et al., 1998). To investigate the Bap1 
expression level in lymphoid tissues, Bap1 expression was analyzed in 
major immune organs, including bone marrow, thymus, spleen, and 
lymph node, by quantitative PCR and Western blotting. Bap1 mRNA was 
expressed highly in thymus and, to a lesser extent, in spleen, lymph node, 
and bone marrow (Figure 14A). Bap1 protein was also detectable in the 
thymus and other lymphoid tissues (Figure 14B). These results strongly 
suggest that Bap1 functions in the immune system and, especially, in the 
thymus. To examine this possibility in detail, Bap1 expression was 
analyzed during T cell differentiation. In particular, Bap1 mRNA was 
highly expressed in the DN stage and decreased gradually with maturation 
(Figure 15A). The DN population was fractionated for further subdivision 
into four stages (DN1−4). Bap1 was highly expressed in DN2 stage and 
was maintained through stages DN3 and DN4. Based on these 
observations, it was proposed that BAP1 affects early T cell 
differentiation and thymocyte maturation in CD4 or CD8 single-positive 
cells. 
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Impaired thymocyte development in Bap1-deficient mice 
 
 To clarify the function of Bap1 specifically in T cell 
development, mice bearing a LoxP-flanked gene encoding Bap1 (Bap1fl/fl) 
were bred with mice expressing the Cre recombinase under the control of 
the proximal Lck promoter (Lck-Cre) to generate mice with Bap1-
deficient thymocytes (Lck-Cre; Bap1fl/fl). The floxed Bap1 allele was 
efficiently deleted in total thymocytes from Lck-Cre; Bap1fl/fl mice 
(Figure 16). To confirm the deletion of Bap1 during T cell development, 
quantitative RT-PCR was used to analyze the level of Bap1 mRNA in 
sorted DN cell subsets, and Bap1 was completely deleted in DN4 stage. 
Next, thymocyte development was analyzed in Lck-Cre; Bap1fl/fl mice and 
control mice. The thymus gland was markedly reduced in size in Lck-Cre; 
Bap1fl/fl mice compared with control mice. The Bap1-deficient mice had 
about one-third fewer thymocytes than the control mice (Figure 17). 
Fluorescence-activated cell sorting (FACS) analysis showed that the 
Bap1-deficient mice had reduced percentages of CD4 SP and CD8 SP 
cells, but slightly increased percentages of DN cells (Figure 18A). In 
addition, the percentages of both peripheral CD4 SP and CD8 SP T cells 
in the spleen were lower, remarkably so, than in control mice (Figure 
18B), and the total number of splenocytes or lymphocytes in the Bap1-
deficient mice was 2- or 3-fold lower than in the control mice, 
respectively (Figure 17). Moreover, all sub-populations of thymocytes in 
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the Bap1-deficient mice had less cellularity rather than did those in the 
control mice (Figure 19), although the absolute number of DN cells was 
only mildly reduced. Furthermore, to test whether the absence of Bap1 
leads to structural defects in the thymus, a histological analysis was 
performed. The architecture of the thymus was notably changed in the 
Bap1-deficient mice, with a much smaller medulla (Figure 20). 
Collectively, these data indicate that Bap1 is essential for normal 
thymocyte development.  
 
Impaired pre-TCR signaling in Bap1-deficient DN thymocytes  
 
 As described above, Bap1 was highly expressed in DN cells, as 
compared to other T cell subsets (Figure 15A), and there was a smaller 
reduction in the ratio of DN stage cells to DP or SP cells (Figure 19). 
Therefore, it was questioned whether the dramatic reduction in thymic 
cellularity in Bap1-deficient mice could be due to an imperfection in the 
early T cell progenitor development during the DN stage. It was expected 
that Bap1 would affect thymocyte development beginning at the transition 
from DN3 to DN4 stage, which is a critical checkpoint for early thymic 
differentiation. To gain insight into the roles of Bap1 in DN cells, such 
cells were fractionated into DN1, DN2, DN3, and DN4 stages by staining 
for CD44 and CD25 as described (Ceredig and Rolink, 2002; Codfrey et 
al., 1993). The percentage of cells in the DN3 population was increased   








Figure 14. The expression of Bap1 mRNA and protein are high in 
thymus. 
 
(A) Quantitative PCR analysis of Bap1 expression in mouse lymphoid 
tissues. BM, bone marrow; Thy, thymus; Spl, spleen; LN, lymph nodes. 
Results are presented relative to β-actin expression. Data are from two 
independent experiments.  
(B) Immunoblot analysis of Bap1 expression in mouse lymphoid tissues. 
β-actin serves as a loading control. Data are representative of two 
independent experiments.   













Figure 15. Bap1 mRNA is highly expressed in DN thymocyte.  
 
(A) Quantification of Bap1 mRNA expression in sorted mouse 
thymocytes subsets. DN; double negative T cells; DP, double positive T 
cells; SP4, CD4 single positive T cells; SP8, CD8 single positive T cells. 
Results are presented relative to β-actin expression (n=2). (B) 
Quantitative PCR analysis of Bap1 mRNA expression from sorted DN1-
DN4 populations. Results are presented relative to β-actin expression 
(n=3).   











Figure 16. Deletion of the Bap1 gene in Lck-Cre; Bap1fl/fl mice 
severely reduced the expression of Bap1 in the thymocytes. 
 
(A) Quantitative Bap1 RT-PCR was performed on total thymocytes from 
the Lck-Cre; Bap1fl/fl mice and littermate control mice. Data are from 
four experiments. The expression of β-actin serves as a loading control. 
Data are shown as mean SEM.  
(B) Relative expression of Bap1 mRNA in sorted DN subsets. The 
expression of β-actin serves as a loading control. Data are from two 
experiments and shown as mean SEM.   














Figure 17. Thymocytes differentiation in Bap1 conditional knockout 
mice was impaired.  
 
Total numbers of thymocytes (left, n=16), splenocytes (middle, n=6) and 
lymphocytes (right, n=2) were quantified by multiplying total live cell 
numbers by the fraction of cells.  Error bars indicates SD.   









(A) Total thymocytes of Bap1-deficient and control mice were analyzed 
for CD4 and CD8 surface staining by flow cytometry. Numbers within 
boxes of contour diagrams indicate the percentages of cells. Data are 
representative of fifteen independent experiments. 
(B) Phenotype of peripheral T cells was analyzed by flow cytometry by 
surface staining for CD4 and CD8 on control and Bap1-deficient 
splenocytes. Numbers adjacent to boxes of contour diagrams indicate the 
percentages of cells. Data are representative of six independent 
experiments. 
  
































Figure 19. Bap1 deletion impacts thymic and splenic cellularity. 
 
The absolute cell numbers of thymic subpopulations (A, n=9) or splenic 
subpopulations (B, n=3) in littermate control and Bap1-deficient mice. 
The subpopulations are determined by FACS analysis as shown in Figure 
18.   









Figure 20. The structure of thymus is impaired in Bap1-deficient 
mice. 
 
Thymus sections from control mice and Lck-Cre; Bap1fl/fl mice. Each 
tissue section is stained with hematoxylin and eosin; the cortex (darker, 
outer area of dotted line) and medullar (lighter, inner area of dotted line) 
can be distinguished by the intensity of the staining. M, medullar; C, 
cortex.  
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among Bap1-deficient thymocytes in comparison with the controls 
(Figure 21A). In addition, the total cellularity of the DN3 population in 
Bap1 conditional knockout mice was not significantly different from that 
in the control mice, but it was markedly decreased in the DN4 population. 
Furthermore, compared to the controls, the DN3/DN4 ratio was two-fold 
higher in Bap1-deficient mice (Figure 21B). Taken together, these data 
suggest that thymocyte development in the Bap1-deficient mice, in which 
the floxed Bap1 alleles were substantially deleted at DN3 stage, was 
arrested at DN3 stage such that the DN3-to-DN4 transition was impaired. 
 During the DN stage, cells committed to the T cell lineage 
undergo TCRβ gene rearrangements, in which the TCRβ chain associates 
with pre-Tα and CD3 elements to form the pre-TCR complex. This 
process, known as β-selection, is a critical checkpoint in T cell 
development (Michie and Zúñiga-pflücker, 2002). It was thought that the 
arrest in the DN3-to-DN4 transition in Bap1-deficient mice could be due 
to a defect in β-selection. To investigate this possibility, TCRβ chain 
expression was analyzed in DN stage cells by flow cytometry. The 
expression of intracellular TCRβ in the DN cell populations was reduced 
in Bap1-deficient mice compared with that in control mice (Figure 22A). 
Moreover, the surface expression of TCRβ on DN cells was greatly 
reduced (70−80%) in Bap1-deficient mice (Figure 22B), indicating that 
the block at DN3 stage might be due to a lack of sufficient TCRβ 
expression. In contrast, the pre-Tα transcript level in the DN cell 
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populations was unchanged in Bap1-deficient mice compared with control 
mice. Thus, I concluded that abnormal TCRβ expression was the main 
reason for the defect in the DN3-to-DN4 transition in Bap1-deficient 
mice, and that Bap1 is required for pre-TCR signaling to pass the β-
selection checkpoint by providing sufficient TCRβ chain expression.  
 
Defects in the maturation of SP thymocytes in Bap1-deficient mice 
 
 In brief, Lck-Cre; Bap1fl/fl mice exhibited a block in thymocyte 
development at DN3 stage confirming a requirement for wild-type Bap1 
in pre-TCR signaling to facilitate the transition from DN to DP cells. In 
addition to the reduction in DP thymocyte cellularity, Bap1-deficient mice 
exhibited a dramatic reduction in the number of CD4 or CD8 SP cells, 
suggesting the existence of a defect in positive selection (Figure 19). 
Similar phenotypes were observed in peripheral CD4 and CD8 SP T cells 
in the spleen in Bap1 conditional knockout mice (Figure 19). To assess 
the requirement for Bap1 during positive selection in more detail, 
transgenic TCRs were introduced into a Bap1-deficient background. HY-
specific TCR transgenic mice (RAG-2 knockout background) was 
introduced to the CD4-Cre; Bap1fl/fl mice. All thymocytes in a TCR 
transgenic mouse express a single TCR with the same affinity for a 
peptide-MHC complex. The HY TCR specifically recognizes a peptide 
from male HY antigen presented on H-2Db. In female HY TCR transgenic 
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mice, the HY+ thymocytes are positively selected to the CD8 lineage. The 
selection of T cells carrying this transgenic TCR can be followed using a 
clonotypic antibody, T3.70. The HY TCR transgenic Bap1-deficient 
female mice exhibited severely impaired production of CD8 SP T cells; 
the percentage of CD8 SP cells in the mutant mice was half that in the 
control mice (Figure 23, left panel). Additionally, staining with anti-T3.70 
antibodies revealed a decreased percentage of positively selected mature 
CD8 SP (T3.70hiCD4-CD8+) cells in Bap1-deficient HY TCR transgenic 
mice, as compared to relative control mice (Figure 23, middle panel). The 
CD4/CD8 profile of the cells gated T3.70hi indicated the failed maturation 
of CD8 SP cells (Figure 23, right panel). The absolute number of CD8 SP 
T cells in the Bap1-deficient mice was approximately half of that in the 
control mice; nevertheless no large difference in total cellularity was 
detected between the control background and Bap1-deficient background 
(Figure 24A). Thymocyte maturation occurs with down-regulation of the 
heat-stable antigen CD24; thus, CD24 decreases in positively selected 
mature SP thymocytes (Sommers et al., 2005). By staining for CD24, it 
was again observed fewer CD24lo SP T cells among the T3.70hi cells in 
CD4-Cre; Bap1fl/fl mice, as compared to control mice (Figure 24B). As 
described previously, Bap1 deficiency resulted in fewer peripheral T cells 
in the spleen (Figure 18B and 19). Taken together, these data demonstrate 
that Bap1 deficiency led to fewer mature T cells both in the thymus and in 
the peripheral tissues. Thus, Bap1 was dispensable for positive selection   






Figure 21. The transition from DN3 to DN4 stage is blocked in Bap1-
deficient mice. 
 
(A) Single-cell suspensions of thymocytes from control or Bap1-deficient 
mice were stained with antibodies to CD4, CD8, CD44 and CD25. 
Numbers in quadrants indicate the percentage of cells. Data are 
representative of eight independent experiments.   
(B) Left, the absolute cell numbers of thymocytes from DN1 to DN4 
subpopulations (n=8). Right, ratio of DN3 T cells to DN4 T cells.  
  























Figure 22. Pre-TCR signaling is defective in Bap1-deficient mice.  
 
(A) Intracellular staining of TCRβ on gated DN thymocytes. Numbers 
above bracketed lines indicate the percent of TCRβ cells. Data are 
representative of three independent experiments. The mean fluorescence 
intensity of intracellular TCRβ was calculated. 
(B) Surface staining of TCRβ on gated DN thymocytes. Numbers above 
bracketed lines indicate the percent of TCRβ cells. Data are representative 
of three independent experiments. The mean fluorescence intensity of 
surface TCRβ was calculated. 
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and maturation during late T cell differentiation, as well as early T cell 
differentiation in the DN stage. It remains to be defined whether the 
positive selection of CD4 SP thymocytes is affected by a loss of Bap1, as 
in CD8 SP thymocytes; this issue could be resolved by crossing Bap1-
deficient mice with another TCR transgenic mouse line (e.g., OT-II mice).  
 
Weakness of TCR-mediated signaling in Bap1-deficient mice 
 
 Signaling cascades arising from the TCR drive the transition of 
DP thymocytes to SP thymocytes. My observation that Bap1 plays a role 
in the generation of SP thymocytes suggests that Bap1 contributes to TCR 
signal transduction in the thymus. To determine whether Bap1 affects 
TCR-mediated signaling, intracellular signaling events, including calcium 
mobilization and extracellular signal-regulated kinase (ERK) activation, 
were analyzed in total thymocytes from control and Bap1-deficient mice. 
During the positive selection of thymocytes, calcium signaling and ERK 
phosphorylation have pivotal roles in transducing the proximal TCR 
signal to downstream effectors. To analyze the requirement for Bap1 in 
these signaling cascades, thymocytes were activated by TCR crosslinking 
with anti-CD3 plus anti-CD4 antibodies or with phorbol 12-myristate 13-
acetate (PMA) plus ionomycin. Thymocytes from Bap1-deficient mice 
exhibited a lower TCR-driven calcium flux than did thymocytes from 
control mice (Figure 25A). The TCR-mediated phosphorylation of ERK 
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by intracellular staining was also evaluated. ERK phosphorylation in 
Bap1-deficient mice was increased to a lesser degree than in control mice 
(Figure 25B). In sum, these data suggest that the loss of Bap1 resulted in 
the TCR-mediated activation of calcium and ERK signaling, which means 
that Bap1 is a critical part of TCR signaling. 
 Apart from thymocyte differentiation, it was also assessed 
whether Bap1 functions in the activation of T cells. To this end, it was 
assessed that the ability of Bap1-deficient sorted naive splenic CD4 SP or 
CD8 SP T cells (CD44loCD62LhiCD4+ or CD44loCD62Lhi CD8+, 
respectively) to respond to stimulation with plate-bound anti-CD3 and 
anti-CD28 antibodies. Unexpectedly, a greater percent of memory T cells 
(CD44hiCD62Llo) was increased in Lck-Cre; Bap1fl/fl mice, as compared to 
control mice (Figure 26A). This could be explained by the fact that the 
absolute numbers of naive and memory CD4 or CD8 SP T cells were 
significantly downregulated in the Bap1-deficient mice (Figure 26B). 
When sorted naive T cells were cultured in medium only, the T cell 
activation marker CD69 was unchanged in both control and Bap1-
deficient mice (Figure 26C). However, upon the activation of naive T 
cells via the TCR with anti-CD3 and -CD28 antibodies, CD69 expression 
was induced on the surface of CD4 or CD8 SP splenic T cells in the 
control mice. The SP T cells of the Bap1-deficient mice also showed an 
increased CD69 expression level, but the levels were lower than in control 
mice. This observation indicates that the loss of Bap1 led to a reduction in 
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the efficiency of TCR signaling. Thus, Bap1 contributes to TCR-
associated responses for T cell activation.  
 
  





Figure 23. The positive selection of CD8 SP cells is impaired in Bap1-
deficient mice.  
 
(Left) Flow cytometry of thymocytes from control or Bap1-deficient 
female mice expressing a transgene encoding the MHC class I−restricted 
HY TCR. Staining of CD4 and CD8 on total thymocytes. Numbers 
adjacent to boxes of contour diagrams indicate the percentage of cells.  
(Middle) Staining with antibody to the HY-specific antibody T3.70. 
Numbers above bracketed lines indicate percent T3.70-positive cells. 
(Right) Flow cytometry profiles of the expression of CD4 and CD8 on 
gated T3.70high thymocytes in Bap1-deficient mice or control mice.  
Data are representative of three independent experiments.  
  















Figure 24. The maturation of thymocytes is defected in Bap1-deficient 
mice.  
 
(A) Total cell number of thymocytes (left, n=3), splenocytes (middle, n=2) 
and thymic CD8 T cells (right, n=3) of CD4-Cre; Bap1fl/fl; HY mice and 
Bap1fl/fl; HY mice were quantified. Data are shown as mean SEM.  
(B) FACS analysis by staining of CD24 and T3.70 on total thymocytes of 
CD4-Cre; Bap1fl/fl; HY mice and Bap1fl/fl; HY mice. Numbers adjacent to 
boxes of contour diagrams indicate the percentage of cells. Data are 
representative of three independent experiments.  
  


























Figure 25. TCR signaling is impaired in Bap1 conditional KO mice.  
 
(A) Calcium flux in total thymocytes from control and Lck-Cre; Bap1fl/fl 
mice after stimulation with anti-CD3-biotin antibody and anti-CD4-biotin 
antibody, followed by streptavidin crosslinking. The downward arrow 
indicates the time when streptavidin was added. Data are representative of 
three independent experiments.  
(B) ERK phosphorylation of total thymocytes from Lck-Cre; Bap1fl/fl mice 
and littermate control mice by TCR stimulation was analyzed by 
intracellular staining.  
  























Figure 26. Deficiency of Bap1 down-regulates the activation of 
peripheral T cells. 
 
(A) FACS analysis of the expression of CD44 and CD62L on gated CD4+ 
or CD8+ splenocytes from control and Bap1-deficient mice. Numbers in 
quadrants indicate the percentage of cells. Data are representative of three 
independent experiments.  
(B) The absolute cell numbers of CD44loCD62Lhi naive cells and 
CD44hiCD62Llo memory cells were calculated from three independent 
experiments. Data are shown as mean SEM.  
(C) Flow cytometry of CD69 staining on gated CD4+ or CD8+ T cells 
from control (solid line) or Lck-Cre; Bap1fl/fl (shaded histogram) sorted 
CD44loCD62Lhi splenocytes left unstimulated (Med) or stimulated by 
crosslinking with anti-CD3 and anti-CD28 for 5 hours. Data are 
representative of two independent experiments.  
  



























	   76	  
IV-1. SRG3 stabilizes the SWI/SNF complex by blocking CHFR 
mediated ubiquitylation and degradation 
 
 Post-translational modification of proteins by ubiquitin ligase is a 
central regulator in a variety of cellular processes. The SWI/SNF complex 
is a major transcriptional regulator, and therefore it needs to be carefully 
regulated. SRG3/mBAF155 has been found to play a role as a scaffold for 
other components of the SWI/SNF complex (Sohn et al., 2007), enabling 
the complex to function efficiently when required. It was demonstrated 
that the major components of the complex BRG1, SNF5, and BAF60a 
were stabilized by ectopic expression of SRG3 in vitro. Furthermore, 
BAF155, a human homolog of SRG3, has been reported to mediate the 
stabilization of BAF57 expression (Keppler and Archer, 2010). From 
results in this paper, it was concluded that BRG1, SNF5, and BAF60a 
were ubiquitylated and degraded via the 26S proteasome-mediated 
pathway (Sohn et al., 2007). However, the identity of the ubiquitin ligases 
involved in this process has been unknown. Recent studies have shown 
that E3 ubiquitin ligases are important for the regulation of the SWI/SNF 
complex. TRIP12 interacts with BAF57 and ubiquitinates it (Keppler and 
Archer, 2010). Unkempt, another ubiquitin ligase, is involved in BAF60b 
ubiquitylation in a Rac1-dependent manner, which increases the 
degradation of BAF60b but not of BAF60a or BAF60c (Lorès et al., 
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2010). Here, I show that CHFR, an E3 ubiquitin ligase, ubiquitinates and 
directs BRG1, SNF5, and BAF60a to a proteosomal degradation pathway. 
 CHFR was found to associate with several chromatin remodeling 
factors, which control chromosome stability, and to function as a tumor 
suppressor. CHFR ubiquitinates and negatively regulates histone 
deacetylase 1 (HDAC1), promoting p21 gene expression to induce p21-
dependent cell cycle arrest (Oh et al., 2009). It also synergistically 
maintains genomic stability with another E3 ubiquitin ligase, ring finger 
protein 8 (RNF8), and inhibits tumorigenesis by modulation of histone 
modifications and suppression of ataxia telangiectasia mutated (ATM) 
kinase activation (Wu et al., 2011). CHFR and RNF8 double-knockout 
mice showed low H2A and H2B ubiquitylation, H4K16 acetylation in 
thymocytes and suppressed ATM activation in response to DNA damage 
response, thereby causing T-cell lymphoma to develop. CHFR functions 
as a regulator controlling the stability of HLTF, which belongs to the 
SWI/SNF chromatin remodeling complex family (Kim et al., 2010). All 
these results indicate that CHFR is involved in the regulation of chromatin 
structure by modulating histone modifications and/or ubiquitinating 
several different chromatin remodeling proteins. 
 The SWI/SNF complex has been shown to have the activity of a 
tumor suppressor. It physically interacts with Rb and mediates Rb-
mediated cell cycle arrest (Dunaief et al., 1994). In addition, SNF5 
represses cyclin D1 expression by recruiting the HDAC complex to its 
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promoter (Tsikitis et al., 2005; Zhang et al., 2002). The SWI/SNF 
complex also associates with BRCA1 or c-Myc (Bochar et al., 2000; 
Roberts and Orkin, 2004) and controls p53-mediated transcriptional 
activity, which regulates cell cycle arrest (Ahn et al., 2011; Levine, 1997). 
Some studies have shown that inactivation of SNF5 result in a failure of 
cell cycle arrest caused by p53 defects (DelBove et al., 2009; Isakoff et 
al., 2005). SRG3 was also shown to function as a tumor suppressor by 
modulating p21WAF1/CIP1 expression (Ahn et al., 2011).  
 In contrast, other studies have shown that the expression of the 
SWI/SNF subunits is maintained in human tumor cells. The increase in 
BRG1 level is associated with enhanced tumor cell growth and invasion 
in human gastric and prostate cancer (Sentani et al., 2001; Sun et al., 
2007). BAF57 activity is maintained in prostate cancer while supporting 
androgen receptor (AR) activity; BAF57 inhibitory peptide sufficiently 
blocks androgen-dependent prostate cancer cell proliferation in AR-
positive cells (Link et al., 2008; Link et al., 2005). These results make it 
clear that the robust expression of subunits of the SWI/SNF complex can 
induce cancer cell growth and invasion in a cell context-dependent 
manner. The pathway involved in the maintenance of expression of the 
SWI/SNF complex in several cancer cells remains unknown. Therefore, it 
is crucial to find the mechanism by which the protein level of the 
SWI/SNF complex is regulated. Thus, it is notable that CHFR, a tumor 
suppressor, regulates the ubiquitylation and degradation of the SWI/SNF 
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chromatin remodeling proteins. It is conceivable that CHFR functions as a 
tumor suppressor also by reducing the expression level of the components 
of the SWI/SNF complex in a context-dependent manner with 
implications for the understanding of epigenetics of cell cycle control and 
potentially, cancer pathogenesis. This hypothesis needs to be investigated 
further. 
  












Figure 27. The stabilization model of the SWI/SNF complex.  
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IV-2. Thymocyte-specific deletion of the deubiquitinase Bap1 impairs 
thymocyte development and activation 
 
 The significance of Bap1 in the regulation of thymocyte 
development and activation has not been defined, although previous 
reports have demonstrated the defects of Bap1 led to an aberrant 
developmental phenotypes in hematopoietic cells (Abdel-Wahab et al., 
2012; Abdel-Wahab and Dey, 2013; Peña-Llopis et al., 2012). To 
elucidate the roles of Bap1 in thymus, I used mice for loxP-flanked Bap1 
alleles deleted by T-cell specific Lck promoter-driven Cre recombinase 
that therefore lack Bap1 specifically in T cells. After generation of Lck 
promoter-driven Bap1 conditional knockout mice, it was confirmed that 
highly expressed mRNA and protein of Bap1 in thymus were efficiently 
deleted from Lck-Cre; Bap1fl/fl mice by quantitative real time PCR and 
western blotting, respectively. The thymus size and total thymocyte 
cellularity were significantly reduced in Bap1-deficient mice compared to 
littermate control mice. It was very interesting because Bap1 is usually 
known as a tumor suppressor from many researches. So it was expected 
that Bap1 would have a different role in thymocytes from other 
hematopoietic lineage cells and suspected that Bap1 could affect the cell 
death that would lead to the marked decrease in the thymic cellularity 
when Bap1 was lost. To confirm that, total thymocytes were stained with 
Annexin V and propidium iodide and analyzed by flow cytometry. 
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Unexpectedly, there was no significant difference in the thymocytes 
profile of Annexin V/propidium iodide between Bap1-deficient mice and 
littermate control mice. To analyze the proliferation of Bap1-deficient 
thymocytes, BrdU was injected i.p. and mice were sacrificed 4 hour later 
before BrdU incorporation was measured. The cell proliferation was also 
not changed with Bap1 deletion in all thymic subpopulations. It is 
suggested the possibility that, in thymus, Bap1 is involved in cellular 
processes other than apoptosis or proliferation to regulate thymic 
development.  
 From this paper, it was shown that reduced expression of TCRβ 
chain of the thymocytes and developmental block at DN3 stage in Bap1-
deficient mice. During thymocyte differentiation, only thymocytes that 
have generated a functional TCRβ chain become selected to differentiate 
to the CD4+CD8+ double positive stage. Dβ-Jβ rearrangement is initiated 
at both alleles of the TCRβ gene loci, followed by Vβ-DβJβ 
rearrangement at individual alleles. The TCRβ chain covalently couples to 
the non-polymorphic pre-Tα chain, which together with the CD3 
molecules form the pre-TCR complex. Bap1-loss resulted in 
developmental block at DN3 stage, which suggested a requirement of 
Bap1 for the DN3-DN4 transition. Furthermore, results obtained from this 
paper showed that the percentages and the absolute cell numbers of CD4 
and CD8 SP cells were significantly decreased with Bap1-loss. In the 
attempt to assess the effect of Bap1 defect for the CD4/CD8 SP 
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maturation, the CD4-Cre; Bap1fl/fl mice were crossed with HY-TCR 
transgenic mice. HY-TCR transgenic mice are useful to investigate the 
positive selection or negative selection in female mice or male mice, 
respectively. It was observed that the maturation of CD8 SP thymocytes 
was impaired in HY TCR transgenic Bap1-deficient female mice. These 
outcomes identified Bap1 as an important factor for the positive selection 
of CD4/CD8 SP T cells. There was no difference in male mice with or 
without Bap1, which suggests that Bap1 does not affect negative selection 
of thymocytes. Further work is also needed to elucidate whether Bap1 
actually influences the positive selection of CD4 SP cells as well as CD8 
SP cells.  
 The Ras-ERK and the calcium signaling pathways are required 
for the positive selection of thymocytes and the activation of peripheral T 
cells. In order to closely observe the TCR signaling, calcium influx and 
phosphorylated ERK level in total thymocytes were investigated after 
stimulation with anti-CD3 or PMA and ionomycin. It was found that the 
calcium flux and ERK activation were downregulated in Bap1-deficient 
mice compared to the control mice, suggesting that loss of Bap1 led to the 
insufficient TCR signal transduction. And with stimulation in vitro, the 
naive splenic T cells were not efficiently activated, which is represented 
by down-modulated CD69 expression level, in Bap1-deficient mice 
compared to control mice. Thus, T cell-specific deletion of Bap1 resulted 
in a weakness of TCR-mediated signal followed by inefficiently activated 
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T cells. From all these results, I conclude that Bap1 serves as a critical 
factor during thymocytes development through the β-selection at DN 
stage, positive selection of SP cells and activation of peripheral T cells.  
 One mechanism by which Bap1 could influence the development 
and activation of T cells would be through the chromatin remodeling by 
ubiquitination of histone as a PR-DUB complex to bind at target genes 
and to remove mono-ubiquitin from histone H2AK119 (Abdel-Wahab 
and Dey, 2013; Harbour et al., 2010; Scheuermann et al., 2010; Wiesner 
et al., 2011). The mutant mice of Asxl1, another core subunit of PR-DUB 
complex, showed a dramatic reduction in total thymocytes cellularity 
compared with control mice (Fisher et al., 2010) similarly to Bap1-
deficient mice. The CD4/CD8 subpopulations also showed a significant 
decrease in absolute cell numbers in the Asxl1 mutant mice. Although the 
defective phenotypes of thymocytes development in mutant mice looked 
generally similar, there were some differences between Bap1 and Asxl1 
mutant mice. The results from Asxl1 mutant mice were observed only in 
mice older than 15 weeks not in younger mice and there were no 
markedly differences in the absolute cell numbers of peripheral CD4/CD8 
SP cells or DP cells in Asxl1 mutant mice unlikely in Bap1-deficient mice. 
Previous studies also have suggested the possibility that Bap1 and ASXL1 
may work independently (Abdel-Wahab and Dey, 2013; Dey et al., 2012). 
Thus, I suggest that Bap1 and Asxl1 may function independently during 
thymocytes development, although there are some differences such as a 
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deletion system that the mutant mice of Asxl1 are not designed to control 
the onset timing of ablate Asxl1 in thymus using a conditional mice. 
 Proteins interacting with Bap1 have been identified and the 
representative ones are HCF-1 (Host cell factor 1) and OGT (O-linked β-
N-acetyl-glucosamine transferase) (Dey et al., 2012; Machida et al., 2009; 
Misaghi et al., 2009; Yu et al., 2010; Yu et al., 2014). HCF-1 is an 
important transcriptional regulator of the cell cycle, which associates with 
diverse histone-modifying molecules such as histone methyltransferases. 
Bap1 KO splenocytes showed decreased HCF-1 expression and Bap1 
deubiquitinases HCF-1 to inhibit its proteasomal degradation (Dey et al., 
2012). Also, Bap1 form a complex with OGT and regulates the stability 
of OGT. OGT is an enzyme involved the O-GlcNAc (O-linked β-N-
acetyl-glucosamine) cycling, which catalyzes the addition of the O-
GlcNAc to proteins (Mcclain et al., 2002). In addition to that Bap1 
directly regulates the stability of HCF-1 or OGT, it is possible that those 
molecules form a complex to affect the stability or function of another 
protein such as peroxisome proliferator activator receptor γ coactivator 1α 
(PGC-1α) (Yang et al., 2012). Bap1 deubiquitylates and thus stabilizes 
OGT, which O-GlcNacylates HCF1 and activates it. Activated HCF1 
recruits OGT to O-GlcNacylate PGC-1α. This modification enables Bap1 
to bind and deubiquitylate PGC-1α that is stabilized and can promote 
gluconeogenesis. Bap1 has also been shown to form a ternary complex 
with HCF1 and the transcription factor Yin Yang 1 (YY1) that controls 
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the transcription of genes involved in cell proliferation. Specifically, Bap1 
interacts with the zinc fingers of YY1 through its coiled-coil motif and is 
recruited together with HCF1 to the promoter of the gene that encodes a 
component of the mitochondrial respiratory chain3 (Yu et al., 2010). 
Immunoprecipitation assay in mouse showed Bap1 interacted with HCF-1 
and OGT in the spleen (Dey et al., 2012). Using a proteomic approach, it 
was identified that HCF-1 was an interacting protein of Bap1 also in 
thymus. Furthermore, previous study using T cell-specific mutagenesis of 
the Ogt allele presented the necessity of the OGT in the thymic 
development (O’Donnell, 2004) and several evidences have suggested the 
relation between glycosylation and the thymocyte development (Gambetta 
et al., 2009; Marth and Grewal, 2008; Zhou et al., 2014). Further work is 
needed to elucidate how exactly Bap1 and other molecules form a 
complex in thymus and what the target genes are to be affected by the 
complex.  In this paper, I propose that Bap1 roles as a critical regulator 
with variable partners to successfully complete the thymocyte 
development, maturation and activation.   
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SRG3에 의한 SWI/SNF 염색사 리모델링 복합체의 안정화 및 
BAP1 이 흉선세포 분화에 미치는 영향에 대한 연구 
 
정 인 경 
 
 T 세포는 세포성 면역 반응에 있어서 중요한 매개체이다. 
골수에서 유래한 T 세포 전구체는 흉선으로 들어가 체계적이고 
복잡한 과정을 거쳐 분화, 선택 과정을 지 기능을 가지는 T 세포로 
성숙한다. T 세포 분화가 일어나는 단계들은 계통 특이적 유전자의 
전사 조절과 TCR 유전자의 재배열에 의해 제어된다. Notch, GATA-3, 
E2A/HEB, Id, c-Myb, ThPOK, Runx 복합체, Ikaros 등의 다양한 
유전자의 전사 유무가 T 세포의 계통 결정에 중요한 역할을 한다. 
또한 TCR 유전자의 재배열이 성공적으로 일어나야만 통과할 수 
있는 β-selection 과 긍정적 선별과정 역시 성숙한 T 세포의 생성에 
필수적이다. 히스톤 수정 효소와 염색사 리모델링 복합체에 의해 
조절되는 염색사의 상태가 유전자의 발현 여부를 결정한다.  
 이 논문에서 우리는 염색사의 상태를 변화시키는 역할을 
하는 염색사 리모델링 복합체인 SWI/SNF 복합체의 주요 구성 
단백질에 대해 연구하였다. BRG1, SNF5, BAF60a 가 유비퀴틴화 
되어 분해되는 과정을 SRG3 가 억제한다는 것이 이전 연구를 통해 
알 수 있었다. 선행연구를 통해 SWI/SNF 염색사 리모델링 복합체가 
흉선세포의 분화과정에 중요한 역할을 한다는 것과 SWI/SNF 
복합체의 안정화는 유비퀴틴화에 의해 조절된다는 것을 알 수 
있었다. 이 논문에서는 특별히 SRG3 가 SNF5, BRG1, BAF60a 의 
프로테아솜에 의해 매개되는 분해 과정을 억제함으로써 그 
단백질들을 안정화시켜 궁극적으로 SWI/SNF 복합체의 안정화에 
중요한 역할을 한다는 것을 밝혀내었다. 한편, E3 유비퀴틴 
결합효소인 CHFR 은 종양 억제 인자로 잘 알려져 있으며 세포주기 
조절과 종양 생성과정에 중요한 역할을 한다. CHFR 은 BRG1, SNF5, 
BAF60a 에 결합하여 유비퀴틴화 시킴으로써 프로테아솜 매개 
과정을 통해 분해 되도록 유도한다. SRG3 는 이러한 CHFR 과 다른 
분자들의 상호작용을 억제함으로써 복합체의 안정화를 가져온다는 
사실을 밝혀내었다.  
 다음으로 우리는 탈유비퀴틴효소인 Bap1 의 흉선세포 분화 
과정에서의 기능에 대해 알아보았다. Bap1 결핍 생쥐는 
배아상태에서의 발생 이상과 미엘로이드 게통 세포 증식 등의 
비정상적인 현상을 보인다. 이 연구에서는, Bap1 이 T 세포 분화에 
미치는 영향을 알아보기 위하여 Lck-Cre mouse 를 이용하여 Bap1 
유전자를 흉선에서 특이적으로 제거하였다. 그를 통하여 pre-TCR 
신호전달 과정과 TCR 신호 전달을 통한 T 세포 분화와 활성화에 
Bap1 이 중요한 역할을 한다는 것을 밝혀내었다. Bap1 결핍 T 세포는 
DN3 에서 DN4 단계로 넘어가지 못하며 TCRβ 발현이 낮아진다. 
또한 TCR 형질 도입 생쥐 (HY-TCR 형질 도입 생쥐)에서 Bap1 이 
결핍되는 경우, T 세포의 긍정적 선별과정 역시 현저히 감소되는 
것을 확인할 수 있다. TCR 을 통해 들어오는 신호에 의해 발생하는 
칼슘 증가와 ERK 의 활성화 역시 Bap1 이 결핍되는 경우 제대로 
일어나지 않으며, TCR 자극에 의한 말초 T 세포의 활성화에도 
문제가 발생한다. 이 결과들을 통하여, Bap1 이 T 세포 발생에 중요한 
인자임을 확인하였으며 흉선세포의 활성화에 필요한 TCR 신호 전달 
과정에도 Bap1 이 관여한다는 것을 밝혀내었다.  
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